Next Article in Journal
Vesiculobullous Diseases
Previous Article in Journal
Effective Balloon Pulmonary Angioplasty in a Patient with Chronic Thromboembolic Complications after Ventriculoatrial Shunt for Hydrocephalus in von Hippel–Lindau Disease
 
 
Review

MDR Tuberculosis Treatment

1
Infectious Diseases Department, Vall d’Hebron University Hospital, PROSICS Barcelona, Universitat Autònoma de Barcelona, 08135 Barcelona, Spain
2
Mycobacteria Infection Study Group from Spanish Society of Infectious Diseases and Clinical Microbiology, 28003 Madrid, Spain
3
Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, 08135 Barcelona, Spain
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Patrick Geraghty
Medicina 2022, 58(2), 188; https://doi.org/10.3390/medicina58020188
Received: 1 December 2021 / Revised: 13 January 2022 / Accepted: 15 January 2022 / Published: 26 January 2022
(This article belongs to the Special Issue Treatment of Drug-Resistant Tuberculosis)
Multidrug-resistant (MDR) tuberculosis (TB), resistant to isoniazid and rifampicin, continues to be one of the most important threats to controlling the TB epidemic. Over the last few years, there have been promising pharmacological advances in the paradigm of MDR TB treatment: new and repurposed drugs have shown excellent bactericidal and sterilizing activity against Mycobacterium tuberculosis and several all-oral short regimens to treat MDR TB have shown promising results. The purpose of this comprehensive review is to summarize the most important drugs currently used to treat MDR TB, the recommended regimens to treat MDR TB, and we also summarize new insights into the treatment of patients with MDR TB. View Full-Text
Keywords: tuberculosis; MDR; treatment tuberculosis; MDR; treatment
MDPI and ACS Style

Espinosa-Pereiro, J.; Sánchez-Montalvá, A.; Aznar, M.L.; Espiau, M. MDR Tuberculosis Treatment. Medicina 2022, 58, 188. https://doi.org/10.3390/medicina58020188

AMA Style

Espinosa-Pereiro J, Sánchez-Montalvá A, Aznar ML, Espiau M. MDR Tuberculosis Treatment. Medicina. 2022; 58(2):188. https://doi.org/10.3390/medicina58020188

Chicago/Turabian Style

Espinosa-Pereiro, Juan, Adrian Sánchez-Montalvá, Maria Luisa Aznar, and Maria Espiau. 2022. "MDR Tuberculosis Treatment" Medicina 58, no. 2: 188. https://doi.org/10.3390/medicina58020188

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop